An enhancer is a short stretch of DNA that boosts the activity of a gene, often from a surprisingly long distance away. Unlike most regulatory elements, enhancers can work regardless of their orientation on the DNA strand and regardless of whether they sit thousands or even millions of base pairs from the gene they control. First discovered over 40 years ago in a monkey virus called SV40, enhancers have turned out to be one of the most important tools cells use to decide which genes to turn on, in which tissues, and at what level.
How Enhancers Differ From Promoters
Every gene has a promoter, a stretch of DNA right next to the gene’s starting point where the cell’s transcription machinery physically assembles to begin reading the gene. Promoters are fixed in place. Enhancers, by contrast, can sit far upstream, far downstream, or even within the gene itself, nested inside non-coding stretches called introns. Some enhancers operate from over a million base pairs away from the gene they regulate.
The other defining trait is orientation independence. If you flipped a promoter backward, it would stop working. Enhancers function in either direction. This flexibility is what originally set them apart when researchers first noticed that a small viral DNA sequence could boost gene activity no matter where it was placed relative to a promoter.
How Enhancers Communicate With Genes
The distance between an enhancer and its target gene raises an obvious question: how does a signal travel across all that intervening DNA? The answer is that it doesn’t travel at all. Instead, the DNA physically loops so the enhancer and the promoter come into direct contact, like pinching a long ribbon so two distant points touch.
This looping is orchestrated by a protein complex called Mediator, which acts as a bridge. Mediator sits at both the enhancer and the promoter of actively transcribed genes. When specialized proteins called transcription factors bind to the enhancer, they recruit Mediator, which undergoes a shape change and then connects with another protein ring called cohesin. Cohesin can encircle two segments of DNA and hold them together, physically stabilizing the loop. The result is that transcription factors at a distant enhancer end up face to face with the gene-reading machinery at the promoter, and transcription ramps up.
Chemical Tags Mark Enhancer Activity
Not every enhancer is active at all times. Cells use chemical tags on the proteins that package DNA (called histones) to flag which enhancers are switched on, which are standing by, and which are silent. Two tags are especially important.
The first, a single methyl group added at a specific spot on histone H3 (known as H3K4me1), marks a region as having enhancer potential. But this tag alone doesn’t mean the enhancer is currently active. It may be in a “poised” state, ready to fire but waiting for the right signal. The second tag, an acetyl group at a nearby spot (H3K27ac), is what separates active enhancers from poised ones. When both marks are present, the enhancer is driving gene activity. When only the methyl mark is present, the enhancer is primed but quiet. This system allows cells to prepare enhancers in advance and then rapidly activate them in response to developmental cues or environmental signals.
Enhancers Control Tissue-Specific Gene Expression
Nearly every cell in your body carries the same DNA, yet a brain cell looks and behaves nothing like a muscle cell. Enhancers are a major reason why. Different cell types activate different sets of enhancers, which in turn switch on different combinations of genes. Brain-specific enhancers, for instance, tend to regulate genes involved in building synapses and extending axons. Muscle-specific enhancers target genes for contractile fibers and the structural scaffolding of muscle cells. Blood cell enhancers drive genes related to immune signaling.
Research published in Genome Research found that enhancers with tissue-specific activity are disproportionately located within introns (the non-coding segments inside genes), where they regulate genes with specialized tissue functions. By contrast, enhancers that are shared across many tissues tend to sit in intergenic regions, between genes, and regulate housekeeping functions that all cells need. Highly specialized tissues like the brain and skeletal muscle show the strongest enrichment of these intronic, tissue-specific enhancers.
Super-Enhancers
Some genes need more than a single enhancer to reach the expression levels a cell requires. Super-enhancers are clusters of individual enhancers packed closely together on the genome, collectively binding unusually high levels of Mediator and transcription factors. They tend to control genes that define a cell’s identity. In embryonic stem cells, for example, super-enhancers drive the genes that maintain the cell’s ability to become any tissue type. In a mature immune cell, a different set of super-enhancers drives the genes that define immune function. Because they concentrate so much regulatory machinery in one place, super-enhancers are especially sensitive to disruption, which makes them relevant to disease.
When Enhancers Go Wrong
Mutations in or near enhancers can cause disease by silencing genes that need to be on, activating genes that should be off, or redirecting an enhancer’s activity to the wrong gene entirely. These conditions have been called “enhanceropathies.”
The examples span a wide range. Deletions 1 to 1.5 million base pairs upstream and downstream of the SOX9 gene on chromosome 17 cause Pierre Robin sequence, a condition affecting jaw and palate development. Tiny duplications in a limb enhancer called ZRS can cause extra fingers or fused digits (polydactyly and syndactyly). A point mutation in an enhancer for the IRF6 gene, which disrupts the binding of two transcription factors, leads to Van der Woude syndrome, a condition involving cleft lip and palate. In some cases, chromosomal rearrangements like inversions or large deletions don’t damage an enhancer directly but instead remove the boundaries that normally keep an enhancer confined to its correct target gene. When those boundaries disappear, the enhancer can be “adopted” by a neighboring gene it was never meant to control, causing conditions like limb syndactyly or brachydactyly.
How Scientists Identify Enhancers
Identifying enhancers used to be painstaking work, testing one DNA fragment at a time. A technology called STARR-seq has changed that. In STARR-seq, millions of candidate DNA sequences are placed into a reporter gene so that any sequence functioning as an active enhancer will produce a messenger RNA containing its own sequence. Scientists then use deep sequencing to count those messenger RNAs. The more copies a particular sequence generates, the stronger its enhancer activity. Each candidate essentially acts as its own barcode, allowing researchers to screen entire genomes and build comprehensive maps of enhancer activity in a single experiment. The signal strength at each peak directly corresponds to how powerfully that sequence can drive transcription.
This approach has been instrumental in cataloging the hundreds of thousands of candidate enhancers scattered across the human genome. One large-scale effort identified close to 135,000 candidate enhancer regions across just five cell types, underscoring how vast and cell-type-specific the enhancer landscape really is.